Evofem Biosciences Inc

Change company Symbol lookup

Select an option...

EVFM Evofem Biosciences Inc

AMZN Amazon.com Inc

CLPR Clipper Realty Inc

VGI Virtus Global Multi-Sector Income Fund

VDE Vanguard Energy Index Fund ETF Shares

VCV Invesco California Value Municipal Income Trust

VCSH Vanguard Short-Term Corporate Bond Index Fund ETF Shares

VBR Vanguard Small-Cap Value Index Fund ETF Shares

V Visa Inc

UPS United Parcel Service Inc

Go

Evofem Biosciences Inc, formerly Neothetics, Inc., is a clinical-stage specialty biopharmaceutical company. The Company develops products to address unmet needs in women's sexual and reproductive health. The Company’s product Amphora, is a Multipurpose Vaginal pH Regulator (MVP-R) designed to regulate vaginal pH to within the normal range of 3.5 to 4.5 even in the presence of semen. This maintains an acidic environment which is inhospitable to sperm as well as certain viral and bacterial pathogens associated with sexually transmitted infections. Amphora is used to prevent urogenital chlamydia and gonorrhea in women. The Company is in the second Phase III clinical trial of Amphora for prevention of pregnancy (AMP002). The Company is currently designing a Phase IIb trial for its second product candidate, a MVP-R to reduce the recurrence of bacterial vaginosis.